And researchers writing in the New England Journal of Medicine voiced their concerns as well with such drugs as Pfizer's popular Celebrex.
Pfizer's medical director, Dr. Gail Cawkwell, insisted that its drugs are safe.
I believe this is a class effect," he said, meaning that the problem also applies to Celebrex and Pfizer's newer, similar drug, Bextra, which remain on the market.
